PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34361816-1	2021	Fostamatinib is a prodrug of the active metabolite tamatinib, which is a spleen tyrosine kinase (Syk) inhibitor used in the treatment of primary chronic adult immune thrombocytopenia and rheumatoid arthritis.	fostamatinib	0-12	spleen associated tyrosine kinase	Rattus norvegicus	73-95	
26116555-0	2015	The Syk Inhibitor Fostamatinib Decreases the Severity of Colonic Mucosal Damage in a Rodent Model of Colitis.	fostamatinib	18-30	spleen associated tyrosine kinase	Rattus norvegicus	4-7	
32305129-7	2020	R406, the active metabolite of fostamatinib, a small molecule kinase inhibitor with high selectivity for SYK, inhibited ANCA-induced pro-inflammatory responses in rat leucocytes in vitro.	fostamatinib	31-43	spleen associated tyrosine kinase	Rattus norvegicus	105-108	
34361816-1	2021	Fostamatinib is a prodrug of the active metabolite tamatinib, which is a spleen tyrosine kinase (Syk) inhibitor used in the treatment of primary chronic adult immune thrombocytopenia and rheumatoid arthritis.	fostamatinib	0-12	spleen associated tyrosine kinase	Rattus norvegicus	97-100	
35228550-6	2022	Two-week treatment of sensitized rats with selective SYK inhibitor fostamatinib strongly blocked circulating DSA production without affecting overall total immunoglobulin levels, and inhibition was sustained up to 5 weeks post-completion of the treatment regimen.	fostamatinib	67-79	spleen associated tyrosine kinase	Rattus norvegicus	53-56